Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04624633
Title AU2 In Relapsed and Untreated CLL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jennifer R. Brown, MD, PhD

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia


Acalabrutinib + Ublituximab + Umbralisib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.